Genky Drugstores Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended September 20, 2019; Provides Earnings Guidance for the First Half and Fiscal Year Ending June 20, 2020
October 21, 2019 at 11:30 am IST
Share
Genky DrugStores Co., Ltd. reported consolidated earnings results for the first quarter ended September 20, 2019. For the quarter, the company reported net sales of ¥28,505 million compared to ¥26,570 million a year ago. Operating income was ¥613 million compared to ¥1,160 million a year ago. Net income attributable to owners of parent was ¥478 million or ¥31.55 per share compared to ¥841 million or ¥54.34 per share a year ago.
The company provided earnings guidance for the first half and fiscal year ending June 20, 2020. For the first half, the company expects net sales of ¥56,500 million, operating income was ¥1,550 million and net income attributable to owners of parent of ¥1,200 million or ¥79.07 per share.
For the year ending June 20, 2020, the company expects net sales of ¥115,000 million, operating income was ¥4,050 million and net income attributable to owners of parent of ¥3,000 million or ¥197.66 per share.
Genky DrugStores Co Ltd is mainly engaged in the management of group companies and the related business. The Company is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.
Genky Drugstores Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended September 20, 2019; Provides Earnings Guidance for the First Half and Fiscal Year Ending June 20, 2020